Startups channel feed – Endpoints News

Startups channel feed

Oncology biotech Bicara unveils IPO pitch same day as Zenas

9 months ago

Autoimmune biotech Zenas files for IPO amid summer lull for public debuts

9 months ago

Illumina Ventures sets out for $300M third fund

9 months ago

Digital health startup Sesame starts offering compounded weight loss shots

9 months ago

Versant and Novartis build 'Chinook 2.0' for RNA therapies in kidney diseases

9 months ago

BridgeBio forms another offshoot with $300M in commitments

9 months ago

After Pfizer layoffs, Array chemists regather at next-gen obesity biotech Ambrosia Biosciences

9 months ago

TCGX and JPM help Pathalys raise $105M to go up against Amgen in subset of kidney disease

9 months ago

Investment in early-stage health tech startups climbed in the first half of 2024, report shows

9 months ago

Metagenomi tinkers with pipeline after CSO departure, says Affini-T and Ionis pacts are progressing

9 months ago

Halda adds $126M to test oral drugs for prostate, breast cancer

9 months ago

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

9 months ago

TPG reveals $580M life sciences fund, which has already backed multiple biotechs

9 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

9 months ago

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

9 months ago

Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder

9 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

9 months ago

Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China

9 months ago

Florida CNS gene therapy biotech shuts down

9 months ago

Exclusive: Devoted Health raises $112M, plots insurance markets expansion

9 months ago

Apogee and Spyre founder launches another autoimmune biotech, and it's got $80M to start

9 months ago

PARP biotech backed by more than five pharmas closes after nine years

9 months ago

Exclusive: Ultragenyx secures first funds for Alzheimer's gene therapy spinout

9 months ago

With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies

9 months ago

First page Previous page 11 12 131415 16 17 Next page Last page